NRx Pharmaceuticals Inc. (NASDAQ:NRXP) price on Wednesday, August 25, fall -12.06% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $12.91.
A look at the stock’s price movement, the close in the last trading session was $14.68, moving within a range at $12.88 and $14.505. Turning to its 52-week performance, $76.99 and $8.39 were the 52-week high and 52-week low respectively. Overall, NRXP moved -27.88% over the past month.
NRx Pharmaceuticals Inc.’s market cap currently stands at around $622.78 million.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that NRXP is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
NRXP’s current price about -12.25% and -6.56% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 46.22, while 7-day volatility ratio is 12.79% and 16.35% in the 30-day chart. Further, NRx Pharmaceuticals Inc. (NRXP) has a beta value of 0.05, and an average true range (ATR) of 2.91.
In the market, a comparison of NRx Pharmaceuticals Inc. (NRXP) and its peers suggest the former has performed considerably weaker. Data shows NRXP’s intraday price has changed -12.06% in last session and 21.16% over the past year. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are up 0.22% and 0.11% respectively in the last trading.
If we refocus on NRx Pharmaceuticals Inc. (NASDAQ:NRXP), historical trading data shows that trading volumes averaged 3.34 million over the past 10 days and 4.46 million over the past 3 months. The company’s latest data on shares outstanding shows there are 47.46 million shares.
The 1.40% of NRx Pharmaceuticals Inc.’s shares are in the hands of company insiders while institutional holders own 4.60% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 94470.0 on May 27, 2021, giving us a short ratio of 0.93. Current price change has pushed the stock -47.09% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NRXP stock continues to rise going into the next quarter.